Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Oncotech Nordic AB
AB
Active
Org 5569896144
Västra Ljungbyvägen 275
Retail sale of bread, cake and confectionery · NACE 4724
Est. 2014
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
SEK 0
EBITDA margin
—
-22% vs 2022
Equity ratio
100.0%
Financial strength
Net profit 2023
SEK -4M
-23% vs 2022
EBITDA — year on year
SEK millions
0M
-1M
-3M
-4M
-5M
0M
2019
0M
0%
2020
-2M
-200%
2021
-3M
-50%
2022
-4M
-33%
2023
Key figures
Annual report 2023
Revenue
SEK 0
—
EBITDA
SEK -4M
-22%
Net profit
SEK -4M
-23%
Total assets
SEK 2,4M
+374%
Equity
SEK 2,4M
+374%
Employees
0
—
Company information
Legal name
Oncotech Nordic AB
Org number
5569896144
Legal form
Aktiebolag
NACE code
4724 · Retail sale of bread, cake and confectionery
Founded
7 november 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
IT, datautveckling, medicinskteknik och diagnostiska applikationer.
Contact
Address
Västra Ljungbyvägen 275
Email
arafn67@protonmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of bread, cake and confectionery
Companies in Båstad
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2019
0M
2020
0M
2021
0M
2022
0M
2023
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
-2M
2021
-3M
2022
-4M
2023
Income statement
SEK thousands
Item
2019
2020
2021
2022
2023
Revenue
656
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−6
—
−2 407
−3 256
−3 977
Depreciation & amort.
−0
−0
−9
−16
−56
EBIT
−6
0
−2 416
−3 272
−4 033
Net financials
—
—
—
—
14
Profit before tax
−6
0
−2 416
−3 272
−4 019
Tax
−0
−0
−0
−0
−0
Net profit
−6
0
−2 416
−3 272
−4 019
Balance sheet
SEK thousands
Item
2019
2020
2021
2022
2023
Total assets
110
110
641
512
2 426
Equity
110
110
641
512
2 426
Long-term debt
0
0
0
0
0
Short-term debt
0
0
0
0
0
Total debt
—
—
—
—
—
Financial ratios
5-year trend
EBITDA margin
-397700000.0%
This company
15.8%
Market median
-2517088708% vs market
2019
2023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2019
2023
Return on equity
-165.7%
This company
18.4%
Market median
-1001% vs market
2019
2023
Net profit margin
-401900000.0%
This company
8.1%
Market median
-4961728495% vs market
2019
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AR
Andre Rafnsson
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
TR
Turidur Rafnsson
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Oncotech Nordic AB also hold positions in
0
other companies.
Person
Role here
Other companies
Andre Rafnsson
Chief Executive Officer
0 companies
Turidur Rafnsson
Deputy Board Member
0 companies